CRL Filing
4Filing Date: Jun 2, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001100682-26-000101open_in_new
Total Value$1.20M
Trades1
Insiders1
Transaction Details
Coleman Glenn
EVP & Chief Financial Officer·Direct
Grant · Acquire
Common Stock
Shares+6.64K
Price$180.71
Total Value$1.20M
Shares Owned After27.75K
Transaction DateMay 29, 2026
Footnotes ▸
Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030.
Post-Transaction Holdings
Coleman Glenn
| Security | Shares | Change |
|---|---|---|
| Common Stock | 27.75K | +6.64K (31.45%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-29
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK: 0001100682
--- Reporting Owner ---
Name: Coleman Glenn
CIK: 0001434369
Role: Officer (EVP & Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-29 | Code: A (Grant or award)
Shares: +6,640 | Price: $180.71
Total Value: $1,199,914.40
Shares Owned After: 27,752 | Ownership: D (Direct)
Footnotes:
[F1] Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030.
--- Footnotes (Complete Index) ---
F1: Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030.
--- Signature ---
/s/ /s/ Glenn Coleman (2026-06-02)